Fig. 1
From: Strategies to improve the immunosuppressive properties of human mesenchymal stem cells
Strategies to obtain human MSCs with improved immunosuppressive properties. CCL8 chemokine (C-C motif) ligand 8, CD274(B7H1) B7 homolog 1 (also known as programmed death-ligand 1), CXCL9 chemokine (C-X-C motif) ligand 9, CXCL10 chemokine (C-X-C motif) ligand 10, CXCR7 chemokine (C-X-C motif) receptor type 7, HLA-DRA major histocompatibility complex, class II, DR alpha chain, ICAM2 intercellular adhesion molecule 2, IDO indoleamine 2,3-dioxygenase, IFN-γ interferon-gamma, MSC mesenchymal stem cell, PTGDS prostaglandin D2 synthase, PTGES prostaglandin E synthase, ULBP1 natural-killer group 2 member D ligand 1, VCAM1 vascular cell adhesion protein 1